State Street’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.38M Sell
1,218,366
-34,074
-3% -$234K ﹤0.01% 2687
2025
Q1
$3.61M Buy
1,252,440
+7,121
+0.6% +$20.5K ﹤0.01% 3013
2024
Q4
$5.85M Sell
1,245,319
-434,910
-26% -$2.04M ﹤0.01% 2891
2024
Q3
$6M Buy
1,680,229
+638,955
+61% +$2.28M ﹤0.01% 2875
2024
Q2
$6.46M Buy
1,041,274
+784,413
+305% +$4.86M ﹤0.01% 2808
2024
Q1
$2.42M Buy
256,861
+73,714
+40% +$696K ﹤0.01% 3219
2023
Q4
$1.24M Hold
183,147
﹤0.01% 3437
2023
Q3
$813K Sell
183,147
-22,800
-11% -$101K ﹤0.01% 3574
2023
Q2
$680K Sell
205,947
-759,641
-79% -$2.51M ﹤0.01% 3631
2023
Q1
$2.75M Buy
965,588
+185,174
+24% +$528K ﹤0.01% 3220
2022
Q4
$5.68M Buy
780,414
+54,897
+8% +$400K ﹤0.01% 2989
2022
Q3
$5.87M Buy
725,517
+76,851
+12% +$622K ﹤0.01% 2985
2022
Q2
$3.18M Sell
648,666
-27,288
-4% -$134K ﹤0.01% 3319
2022
Q1
$16M Sell
675,954
-21,957
-3% -$519K ﹤0.01% 2556
2021
Q4
$12.3M Buy
697,911
+245,599
+54% +$4.34M ﹤0.01% 2790
2021
Q3
$12.8M Buy
452,312
+140,087
+45% +$3.95M ﹤0.01% 2741
2021
Q2
$3.27M Buy
312,225
+57,728
+23% +$605K ﹤0.01% 3428
2021
Q1
$3M Buy
254,497
+15,048
+6% +$177K ﹤0.01% 3268
2020
Q4
$2.8M Buy
239,449
+27,394
+13% +$321K ﹤0.01% 3230
2020
Q3
$1.68M Buy
212,055
+4,957
+2% +$39.3K ﹤0.01% 3272
2020
Q2
$3.79M Buy
207,098
+12,836
+7% +$235K ﹤0.01% 2903
2020
Q1
$2.32M Buy
194,262
+155,213
+397% +$1.85M ﹤0.01% 2994
2019
Q4
$650K Buy
+39,049
New +$650K ﹤0.01% 3483